Smith & Nephew plc Profile Avatar - Palmy Investing

Smith & Nephew plc

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and tra…
Medical - Devices
GB, Watford [HQ]

Ratios

14 Sheets · Starting from 2022
Margins, Growth Rates In %
Ratio 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022
Profitability
Gross Margin
72.69 73.98 73.30 74.14 74.72 74.83 75.33 72.76 73.81 73.53 73.96 69.39 70.40 70.47
Profit Margin
12.51 15.52 13.63 17.62 12.78 10.85 8.85 16.79 16.10 13.52 11.68 9.82 10.05 4.28
Operating Margin
19.17 23.22 20.19 20.45 18.62 16.22 13.55 17.16 19.60 17.60 15.86 6.47 11.38 8.63
EPS Growth
23.26 30.19 -5.80 24.62 -23.46 -9.68 -17.86 91.30 - - -13.64 -6.58 -22.54 7.27 -57.63
Return on Assets (ROA)
10.34 12.99 12.26 12.92 9.55 6.86 5.72 10.68 9.75 8.23 6.45 4.07 4.80 2.24
Return on Equity (ROE)
21.66 22.18 18.26 18.77 13.74 12.40 10.34 19.81 16.52 13.60 11.67 8.49 9.41 4.24
Return on Invested Capital (ROIC)
15.25 18.21 16.86 12.88 12.65 9.15 8.46 10.54 13.37 11.56 9.16 5.99 5.95 5.25
Solvency
Equity Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - - - -
Debt/Assets
25.46 14.77 6.78 8.30 6.72 23.34 20.65 22.47 18.43 18.18 22.01 33.51 30.58 28.82
Debt/Equity
53.33 25.21 10.10 12.05 9.66 42.20 37.32 41.69 31.22 30.06 39.82 69.90 59.97 54.61
Debt/EBITDA
93.36 40.63 11.84 24.54 21.24 135.69 121.54 122.43 91.76 85.01 133.48 213.27 174.83 267.44
Debt/Capitalization
34.78 20.13 9.18 10.75 8.81 29.68 27.18 29.42 23.79 23.11 28.48 41.14 37.49 35.32
Interest Debt per Share USD
1.36 0.81 0.37 0.53 0.45 1.95 1.27 1.91 1.73 1.75 2.42 4.29 3.90 3.39
Debt Growth
-21.11 -39.85 -53.93 45.34 -16.45 336.06 -13.20 11.49 -12.12 1.03 39.73 80.26 -9.51 -13.99
Liquidity
Current Ratio
241.60 235.67 193.76 230.54 210.25 209.98 184.15 187.61 202.90 210.03 205.82 276.30 207.60 224.84
Quick Ratio
133.49 22.65 16.17 19.14 99.91 91.31 87.50 89.91 95.32 103.82 91.05 163.45 108.71 84.00
Cash Ratio
22.25 22.65 16.17 19.14 12.77 8.00 8.93 7.42 12.56 24.91 17.71 104.38 60.53 20.41
Operating Cash Flow Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - - - -
Turnover
Inventory Turnover
110.40 111.70 132.71 118.76 109.34 98.39 93.92 102.25 95.71 93.05 82.90 82.56 83.68 69.84
Receivables Turnover
398.73 - - - - - - 465.35 476.96 439.24 419.87 405.19 392.95 410.06 403.54 431.23 423.43
Payables Turnover
172.82 167.10 202.13 163.11 140.13 138.66 135.75 143.89 130.41 135.63 127.92 136.60 140.79 140.26
Asset Turnover
82.63 83.71 89.95 73.33 74.77 63.19 64.66 63.58 60.58 60.85 55.25 41.41 47.73 52.33
Coverage
Interest Coverage
1,721.43 5,111.11 7,183.33 9,400.00 8,100.00 2,140.00 1,281.63 1,540.38 1,638.60 1,462.71 1,253.85 475.81 741.25 562.50
Asset Coverage
200 400 1,000 700 900 200 200 200 300 300 300 200 200 200
Cash Flow Coverage (CFGR)
61.88 122.89 261.49 192.74 221.74 40.06 69.59 51.45 75.17 63.55 57.06 25.34 26.27 16.30
EBITDA Coverage
2,400 6,700 9,700 13,100 11,900 3,300 2,200 2,400 2,400 2,100 2,000 1,400 1,400 1,100
Dividend Coverage
-300 -400 -300 -300 -200 -200 -100 -200 -200 -200 -100 -100 -100 - -
Time Interest Earned (TIE)
100 100 100 100 100 100 100 100 100 100 100 100 100 100
Market Prospects
Dividend Yield
1.34 1.38 1.76 1.90 1.91 1.52 1.24 2.13 1.81 2.07 1.53 1.76 2.24 2.81
Earnings Yield
5.26 6.44 7.02 7.43 4.44 3.04 1.86 5.99 5.17 4.27 2.88 2.41 3.57 1.92
Price/Earnings (P/E)
1,900.75 1,552.20 1,423.76 1,346.12 2,252.50 3,288.59 5,369.49 1,668.56 1,936.22 2,342.11 3,466.87 4,152.34 2,805.06 5,220.27
Price/Book (P/B)
411.73 344.25 260.00 252.66 309.46 407.82 555.09 330.51 319.78 318.59 404.61 352.39 263.98 221.36
Price/Sales (P/S)
237.85 240.94 194.06 237.21 287.84 356.85 475.07 280.18 311.66 316.64 404.85 407.95 282.01 223.23
Price/Cash Flow (P/CF)
1,247.78 1,111.29 984.12 1,087.94 1,444.51 2,412.28 2,137.37 1,540.81 1,362.46 1,667.90 1,780.92 1,989.57 1,676.00 2,487.44
End of SNNUF's Analysis
CIK: 845982 CUSIP: - LEI: - UEI: -
Secondary Listings